Recombinant ALCAM (Praluzatamab Biosimilar) antibody

Catalog No. ABIN7597922

This anti-ALCAM (Praluzatamab Biosimilar) antibody is a Humanized Chimeric antibody detecting ALCAM (Praluzatamab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant ALCAM (Praluzatamab Biosimilar) antibody (ABIN7597922)

Target: ALCAM (Praluzatamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This ALCAM (Praluzatamab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-ALCAM (Praluzatamab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Praluzatamab Biosimilar Antibody

Specificity: Activated leukocyte cell adhesion molecule, MEMD, CD166 antigen, ALCAM, CD166

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ALCAM (Praluzatamab Biosimilar)

Target: ALCAM (Praluzatamab Biosimilar)

Alternative Name: Praluzatamab Biosimilar

Target Type: Biosimilar

Background: Activated leukocyte cell adhesion molecule, MEMD, CD166 antigen, ALCAM, CD166

UniProt: Q13740

CAS-No: 2145109-70-0